A new specificity, SH7 (Bw75), defined by antisera produced by planned immunization.
SH7 specificity was defined by a group of antisera developed in Shanghai, China by planned immunization. SH7 antibody is cross-reactive with B5 and B15, as demonstrated by the serological reaction patterns obtained during planned immunization. Using 9th and 10th International Histocompatibility Workshop sera, we were able to confirm SH7, TS-1 and B15Kemp as identical specificities. They are equivalent to BW62S and B15Short-Thai. In view of the cross-reaction patterns obtained during planned immunization, SH7 appears to belong to the B5, B15, B35 and Bw70 cross-reactive groups.
Zhao
T M
TM
Shanghai Blood Center, China.
Lee
T D
TD
Davey
R J
RJ
Simonis
T
T
Lee
G
G
Miller
W V
WV
D000939:Epitopes; D005260:Female; D006680:HLA Antigens / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology*; D006801:Humans; D007106:Immune Sera / Q000276:immunology*; D007114:Immunization; D008297:Male; D010641:Phenotype; D012699:Serology
D000939:Epitopes; D006680:HLA Antigens; D015235:HLA-B Antigens; C057904:HLA-B75 antigen; D007106:Immune Sera